MHC Class II risk alleles and amino acid residues in idiopathic membranous nephropathy

Journal of the American Society of Nephrology

Volumn 28, Issue 5, 2017, Pages 1651-1664

  Cui, Zhao ^a   Xie, Li Jun ^a,b   Chen, Fang Jin ^c   Pei, Zhi Yong ^d   Zhang, Li Jie ^a   Qu, Zhen ^a   Huang, Jing ^a   Gu, Qiu Hua ^a   Zhang, Yi Miao ^a   Wang, Xin ^a   Wang, Fang ^a   Meng, Li Qiang ^a   Liu, Gang ^a   Zhou, Xu Jie ^a   Zhu, Li ^a   Lv, Ji Cheng ^a   Liu, Fan ^e   Zhang, Hong ^a   Liao, Yun Hua ^b   Lai, Lu Hua ^c   Ronco, Pierre ^f,g,h   Zhao, Ming Hui ^a,i   more..

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c Peking University   (China)

^d Beijing Computational Science Research Center   (China)

^e Chinese Academy of Sciences   (China)

^f SORBONNE UNIVERSITÉ   (France)

^g Urgences Néphrologiques et Transplantation Rénale Hôpital Tenon 4   (France)

^h HÔPITAL TENON   (France)

ⁱ Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ARGININE; EPITOPE; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; HLA DR ANTIGEN; PHOSPHOLIPASE A2 RECEPTOR;

ALLELE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; GENE INTERACTION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE; GENE; GENETICS; IMMUNOLOGY; PHYSIOLOGY; RISK FACTOR;

ALLELES; AMINO ACIDS; GENES, MHC CLASS II; GLOMERULONEPHRITIS, MEMBRANOUS; HLA-DR ANTIGENS; HUMANS; RECEPTORS, PHOSPHOLIPASE A2; RISK FACTORS;

EID: 85019713590     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016020114     Document Type: Article

References (36)

1. Beck LH Jr., Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
2. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R: Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364: 616-626, 2011
3. Lv J, Hou W, Zhou X, Liu G, Zhou F, Zhao N, Hou P, Zhao M, Zhang H: Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol 24: 1323-1329, 2013
4. Papiha SS, Pareek SK, Rodger RS, Morley AR, Wilkinson R, Roberts DF, Kerr DN: HLA-A, B, DR and Bf allotypes in patients with idiopathic membranous nephropathy (IMN). Kidney Int 31: 130-134, 1987
5. Klouda PT, Manos J, Acheson EJ, Dyer PA, Goldby FS, Harris R, Lawler W, Mallick NP, Williams G: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet 2: 770-771, 1979
6. Ogahara S, Naito S, Abe K, Michinaga I, Arakawa K: Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. Kidney Int 41: 175-182, 1992
7. Hiki Y, Kobayashi Y, Itoh I, Kashiwagi N: Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan. Kidney Int 25: 953-957, 1984
8. Ancian P, Lambeau G, Mattéi MG, Lazdunski M: The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem270: 8963-8970, 1995
9. Beck LH Jr.: The dominant humoral epitope in phospholipase A2 receptor-1: Presentationmatters when serving up a slice of p. J AmSoc Nephrol 26: 237-239, 2015
10. Kao L, Lam V, Waldman M, Glassock RJ, Zhu Q: Identification of the immunodominant epitope region in phospholipase A2 receptormediating autoantibody binding in idiopathic membranous nephropathy. J Am Soc Nephrol 26: 291-301, 2015
11. Fresquet M, Jowitt TA, Gummadova J, Collins R, O'Cualain R, McKenzie EA, Lennon R, Brenchley PE: Identification of amajor epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol 26: 302-313, 2015
12. Seitz-Polski B, Dolla G, Payre C, Girard CA, Polidori J, Zorzi K, Birgy-Barelli E, Jullien P, Courivaud C, Krummel T, Benzaken S, Bernard G, Burtey S, Mariat C, Esnault VL, Lambeau G: Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy. J Am Soc Nephrol 27: 1517-1533, 2015
13. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219, 1999
14. Martí-Renom MA, Stuart AC, Fiser A, Sánchez R, Melo F, Sali A: Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291-325, 2000
15. Webb B, Sali A: Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics 47: 1-32, 2014
16. Sali A, Blundell TL: Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815, 1993
17. Fiser A, Do RK, Sali A: Modeling of loops in protein structures. Protein Sci 9: 1753-1773, 2000
18. CoenenMJ, Hofstra JM, Debiec H, Stanescu HC, Medlar AJ, Stengel B, Boland-Augé A, Groothuismink JM, Bockenhauer D, Powis SH, Mathieson PW, Brenchley PE, Kleta R, Wetzels JF, Ronco P: Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol 24: 677-683, 2013
19. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J: HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 48: 211-219, 2000
20. Fernando MM, Stevens CR, Sabeti PC, Walsh EC, McWhinnie AJ, Shah A, Green T, Rioux JD, Vyse TJ: Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 3: E192, 2007
21. Yang R, Cui Z, Zhao J, Zhao MH: The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBMdisease. Clin Immunol 133: 245-250, 2009
22. MirettiMM, Walsh EC, Ke X, DelgadoM, GriffithsM, Hunt S, MorrisonJ, Whittaker P, Lander ES, Cardon LR, Bentley DR, Rioux JD, Beck S, Deloukas P: A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 76: 634-646, 2005
23. Sekula P, Li Y, Stanescu HC, Wuttke M, Ekici AB, Bockenhauer D, Walz G, Powis SH, Kielstein JT, Brenchley P, Eckardt KU, Kronenberg F, Kleta R, Köttgen A; GCKD Investigators: Genetic risk variants for membranous nephropathy: Extension of and association with other chronic kidney disease aetiologies [published online ahead of print February 4, 2016]. Nephrol Dial Transplant
24. Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C: A genetically determined high setting of TNFalpha influences immunologic parameters of HLA-B8, DR3 positive subjects: Implications for autoimmunity. Hum Immunol 62: 705-713, 2001
25. Smith KJ, Pyrdol J, Gauthier L, Wiley DC, Wucherpfennig KW: Crystal structure of HLA-DR2 (DRA∗0101, DRB1∗1501) complexed with a peptide from human myelin basic protein. J ExpMed 188: 1511-1520, 1998
26. Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, Gyllensten U, Erlich HA: HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci USA 85: 3504-3508, 1988
27. Zerva L, Cizman B, Mehra NK, Alahari SK, Murali R, Zmijewski CM, Kamoun M, Monos DS: Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J ExpMed 183: 829-836, 1996
28. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP: Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43: 321-327, 2011
29. Ronco P, Debiec H: Pathophysiological advances in membranous nephropathy: Time for a shift in patient's care. Lancet 385: 1983-1992, 2015
30. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA: An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26: 2526-2532, 2011
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575, 2007
32. Long JC, Williams RC, Urbanek M: An E-Malgorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56: 799-810, 1995
33. Kim K, Bang SY, Lee HS, Okada Y, Han B, SawWY, Teo YY, Bae SC: The HLA-DRb1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations. Nat Commun 5: 5902, 2014
34. Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW: Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol 6: 490-496, 2005
35. Harkiolaki M, Holmes SL, Svendsen P, Gregersen JW, Jensen LT, McMahon R, FrieseMA, van Boxel G, Etzensperger R, Tzartos JS, Kranc K, Sainsbury S, Harlos K, Mellins ED, Palace J, EsiriMM, van derMerwe PA, Jones EY, Fugger L: T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30: 348-357, 2009
36. Ghosh P, Amaya M, Mellins E, Wiley DC: The structure of an intermediate in class IIMHC maturation: CLIP bound to HLA-DR3. Nature 378: 457-462, 1995